Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABIO

ARCA biopharma (ABIO) Stock Price, News & Analysis

ARCA biopharma logo

About ARCA biopharma Stock (NASDAQ:ABIO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.40
$599.04
52-Week Range
N/A
Volume
290,800 shs
Average Volume
607,995 shs
Market Capitalization
$34.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Stock News Headlines

Hendrick Gambles Big on 20-Year-Old ARCA Star
Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
See More Headlines

ABIO Stock Analysis - Frequently Asked Questions

ARCA biopharma, Inc. (NASDAQ:ABIO) posted its quarterly earnings results on Wednesday, August, 4th. The biopharmaceutical company reported ($48.96) EPS for the quarter, beating analysts' consensus estimates of ($341.28) by $292.32.

Shares of ARCA biopharma reverse split on Tuesday, September 3rd 2024.The 1-12 reverse split was announced on Friday, August 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARCA biopharma investors own include Digital Turbine (APPS), Vuzix (VUZI), Canoo (GOEV), ChargePoint (CHPT) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/04/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABIO
CIK
907654
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.34 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-20.18%
Return on Assets
-19.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
26.61
Quick Ratio
26.61

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.25 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,507,000
Free Float
10,024,000
Market Cap
$34.82 million
Optionable
Optionable
Beta
0.91
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:ABIO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners